A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2004
11/04/2004	CA2520881A1 Ligand-coupled initiator polymers and methods of use
11/04/2004	CA2520655A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	CA2520197A1 Sachet for a pharmaceutical composition
11/04/2004	CA2519552A1 Extruded particles containing adverse agents such as opioid antagonists to decrease drug abuse potential
11/04/2004	CA2517265A1 Trospium containing compositions
11/04/2004	CA2517010A1 Plasmid dna in combination with recombinant vsv for use in prime-boost immunization regimens
11/04/2004	CA2497410A1 Antibacterial pyrazole carboxylic acid hydrazides
11/03/2004	EP1473300A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/03/2004	EP1473050A1 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
11/03/2004	EP1473047A1 Microbial cellulose wound dressing, containing PHMB, for treating chronic wounds
11/03/2004	EP1473033A1 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid
11/03/2004	EP1473032A1 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia
11/03/2004	EP1473031A1 Sucrose ester - C20 to C28 alcohol formulations
11/03/2004	EP1473030A1 Extended release Venlafaxine tablet formulation
11/03/2004	EP1473029A1 Solid dosage form comprising desmopressin
11/03/2004	EP1473003A2 Drug delivery device
11/03/2004	EP1472337A1 Induction of tumor immunity by variants of folate binding protein
11/03/2004	EP1472309A1 Method for preparation of block copolymeric nanoparticles
11/03/2004	EP1472289A1 Stabilization of protein preparations
11/03/2004	EP1472242A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
11/03/2004	EP1472231A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
11/03/2004	EP1472211A1 Emollients and cosmetic compositions
11/03/2004	EP1471995A1 Encapsulation process and encapsulated compositions
11/03/2004	EP1471942A1 Immunocytokine-containing lyophilized preparation
11/03/2004	EP1471941A1 Method of treatment of vulval vestibulitis
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471932A1 Use of a polypeptide for treatment of pruritus in animals
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471925A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions
11/03/2004	EP1471919A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
11/03/2004	EP1471914A1 Pharmaceutical composition for regeneration of cirrhotic liver
11/03/2004	EP1471900A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions
11/03/2004	EP1471899A1 Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
11/03/2004	EP1471896A1 Formulations for inhalation
11/03/2004	EP1471895A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
11/03/2004	EP1471894A1 Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants
11/03/2004	EP1471893A2 Method and device for producing products in web form
11/03/2004	EP1471892A2 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
11/03/2004	EP1471891A2 Polymer-based compositions for sustained release
11/03/2004	EP1471890A2 Pharmaceutical dosage form for mucosal delivery
11/03/2004	EP1471889A2 Oral pediatric trimethobenzamide formulations and methods
11/03/2004	EP1471888A2 Oral trimethobenzamide formulations and methods
11/03/2004	EP1471887A2 Nanoparticulate compositions having lysozyme as a surface stabilizer
11/03/2004	EP1471886A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
11/03/2004	EP1471885A2 Efficient liposomal encapsulation
11/03/2004	EP1471884A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
11/03/2004	EP1471883A2 Method for producing water dispersible dry powders from poorly soluble compounds
11/03/2004	EP1471879A1 Topical glycopyrrolate product
11/03/2004	EP1406728B1 Process for activation of drugs in a vibrational mill
11/03/2004	EP1383399B1 Nutritional supplement to treat macular degeneration
11/03/2004	EP1316559B1 Adenosine derivatives and use thereof
11/03/2004	EP1267842B1 Method for producing a controlled-release tablet using a pore forming agent in the coating
11/03/2004	EP1135182B1 Blood pump without bearing
11/03/2004	EP1121929B1 Composition comprising di- and trisodiumsalts of echinochrome for treating ocular conditions
11/03/2004	EP1071464B1 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
11/03/2004	EP1071400B1 Drug delivery of proteins from polymeric blends
11/03/2004	EP1014939B1 Encapsulation of water insoluble active substances with an amphiphilic character
11/03/2004	EP0907357B1 Non-aqueous controlled release insecticidal gel composition
11/03/2004	EP0788305B1 Composition for inactivating irritants in fluids
11/03/2004	EP0663235B1 Phase separated membrane
11/03/2004	CN2652363Y Analgesic cutting edge dressing plaster
11/03/2004	CN1543361A Synechia inhibitory material
11/03/2004	CN1543359A Compositions and preparation methods for bioavailable oral aceclofenac dosage forms
11/03/2004	CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004	CN1543357A 5-CNAC as oral delivery agent for parathyroid hormone fragments
11/03/2004	CN1543349A Enhanced drug delivery in transdermal systems
11/03/2004	CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004	CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/03/2004	CN1543341A Stabilization of solid thyroid drug formulations
11/03/2004	CN1543340A Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
11/03/2004	CN1543339A Porous matrix comprising cross-linked particles
11/03/2004	CN1543338A Chitin microparticles and their medical uses
11/03/2004	CN1543337A Expandable gastric retention device
11/03/2004	CN1542015A Preparation method and application of harmel seed alkaloid
11/03/2004	CN1542012A Cefetamet sodium and its application of preparing powder injection or dry powder injection for broad-spectrum strong antibiotic injection
11/03/2004	CN1542009A Preparation method and use of dipyridanmole derivative
11/03/2004	CN1542005A Preparation method and use of sulfalene oxazole derivative
11/03/2004	CN1542003A Preparation method and use of trimethoprim derivative
11/03/2004	CN1541714A Gene transfer-mediated angiogenesis therapy
11/03/2004	CN1541708A Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals
11/03/2004	CN1541703A Externally applied preparation for removing dampness and relieving osteodynia
11/03/2004	CN1541699A Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process
11/03/2004	CN1541698A Prepared traditional medicine applied in tumor surgical operation, radiotheraphy and chemotherapy
11/03/2004	CN1541697A Chinese traditional medicine soft capsule for treating chronic cholecystitis and gallstone, and its preparation
11/03/2004	CN1541696A Oyster capsule for gastric disease and its preparation
11/03/2004	CN1541690A Chinese traditional medicine preparation Qimaishen for treating viral myocarditis and its manufacturing method
11/03/2004	CN1541689A Manufacturing technique of fine Fanhuncao granula formulation
11/03/2004	CN1541685A Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis
11/03/2004	CN1541683A Antithrombotic Qilong Capsule
11/03/2004	CN1541682A Insomnia treating traditional Chinese medicine preparation and its preparing process
11/03/2004	CN1541681A Hypertension treating traditional Chinese medicine preparation and its preparing process
11/03/2004	CN1541678A Mastoplasia treating medicine
11/03/2004	CN1541677A Medicinal composition for treating coronary disease and its preparation and application
11/03/2004	CN1541675A Medicine for treating rheumatism and its preparation
11/03/2004	CN1541674A Traditional Chinese drugs fomula for removing alliaceous odor of mouth cavity rapidly
11/03/2004	CN1541669A Prepared traditional Chinese drug Liangfu drop pills for treating epigastric pain
11/03/2004	CN1541668A Osteopathy treating ointment
11/03/2004	CN1541661A Manufacturing technique of acanthopanax root soft capsule
11/03/2004	CN1541658A Cod-liver oil, royal jelly freeze-dry powder capsule and its process

1 ... 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 ... 2991